MC1R has been shown to stimulate HLA-A2-restricted cytotoxic T lymphocytes, enhancing their ability to recognize peptides naturally processed on melanoma cells, further linking immune modulation to tumor immunity (Salazar-Onfray et al., 1997). Here, MC1R is linked to neoplasm.